Small-molecule HDAC and Akt Inhibitors Suppress Tumor Growth and Enhance Immunotherapy in Multiple Myeloma
Mitsuhito Hirano(The University of Tokyo), Arinobu Tojo(Tokyo Medical and Dental University)
Cited by 0
Related Papers
FXYD3 functionally demarcates an ancestral breast cancer stem cell subpopulation with features of drug-tolerant persisters
|Journal of Clinical Investigation|2023|29
Small-molecule HDAC and Akt inhibitors suppress tumor growth and enhance immunotherapy in multiple myeloma
|Journal of Experimental & Clinical Cancer Research|2021|24